Henan Cancer Hospital

This study tests whether a combination of three drugs (fruquintinib, sintilimab, and SOX chemotherapy) can shrink advanced stomach cancer enough to allow surgical removal. About 42 adults with stage IV gastric cancer that has spread to nearby organs or lymph nodes will receive th…

This study tests a new combination of the immunotherapy drug camrelizumab plus chemotherapy (AVD) as a first treatment for people with advanced classical Hodgkin's lymphoma. The goal is to see if this combo can make the cancer disappear completely. About 60 adults aged 18-75 who …

This study tests whether a drug called trilaciclib can prevent bone marrow suppression (low blood cell counts) caused by platinum chemotherapy in people with advanced non-small cell lung cancer. About 41 participants will receive trilaciclib before each chemo session. The main go…